Originally published In Press as doi:10.1074/jbc.M201968200 on May 22, 2002
J. Biol. Chem., Vol. 277, Issue 32, 28923-28933, August 9, 2002
trans Expression of a Plasmodium
falciparum Histidine-rich Protein II (HRPII) Reveals Sorting of
Soluble Proteins in the Periphery of the Host Erythrocyte and Disrupts
Transport to the Malarial Food Vacuole*
Thomas
Akompong
,
Madhusudan
Kadekoppala
,
Travis
Harrison
,
Anna
Oksman§,
Daniel E.
Goldberg§¶,
Hisashi
Fujioka
,
Benjamin U.
Samuel
,
David
Sullivan**
, and
Kasturi
Haldar
§§
From the
Departments of Pathology and
Microbiology-Immunology, Northwestern University Feinberg School of
Medicine, Chicago, Illinois 60611, § Howard Hughes Medical
Institute, Departments of Medicine and Molecular Microbiology,
Washington University School of Medicine, St. Louis, Missouri 63110,
Institute of Pathology, Case Western Reserve University,
Cleveland, Ohio 44106, and ** The W. Harry Feinstone
Department of Microbiology and Immunology, School of Hygiene and
Public Health, Johns Hopkins University,
Baltimore, Maryland 21205
Received for publication, February 27, 2002, and in revised form, May 14, 2002
 |
ABSTRACT |
The heme polymer hemozoin is produced in the food
vacuole (fv) of the parasite after hemoglobin proteolysis and is the
target of the drug chloroquine. A candidate heme polymerase, the
histidine-rich protein II (HRPII), is proposed to be delivered to the
fv by ingestion of the infected-red cell cytoplasm. Here we show that
97% of endogenous Plasmodium falciparum (Pf) HRPII
(PfHRPII) is secreted as soluble protein in the periphery of the red
cell and avoids endocytosis by the parasite, and 3% remains
membrane-bound within the parasite. Transfected cells release 90% of a
soluble transgene PfHRPIImyc into the red cell periphery and contain
10% membrane bound within the parasite. Yet these cells show a minor
reduction in hemozoin production and IC50 for chloroquine.
They also show decreased transport of resident fv enzyme PfPlasmepsin
I, the endoplasmic reticulum (ER) marker PfBiP, and
parasite-associated HRPII to fvs. Instead, all three proteins
accumulate in the ER, although there is no defect in protein export
from the parasite. The data suggest that novel mechanisms of sorting
(i) soluble antigens like HRPII in the red cell cytoplasm and (ii)
fv-bound membrane complexes in the ER regulate parasite digestive processes.
 |
INTRODUCTION |
Plasmodium falciparum is a protozoan parasite that
causes the most virulent of human malarias (1, 2). During the blood stages of infection, it invades and develops within a parasitophorous vacuolar membrane (PVM)1 in a
red cell (3). The parasite exports numerous proteins to the cytoplasm
and membrane of the red cell (4). Association with the host skeleton or
insertion across its membrane is thought to be required to keep the
protein in the periphery of the red cell. Soluble exported proteins are
expected to be ingested with hemoglobin and delivered to the fv within
the parasite (3, 5). The parasite ingests and degrades ~80% of the
hemoglobin in the red cell (3, 5). Ingestion occurs via a specialized organelle called the cytostome, which is a double membrane
invagination of the parasite plasma membrane (PPM) and PVM
(see Fig. 1). The cytostome pinches off to form a large, double
membrane vesicle containing hemoglobin that fuses with the fv where
hemoglobin is degraded (Fig. 1). The released, toxic-free heme is
detoxified by polymerization to hemozoin (6, 7). Heme polymerization is
also likely to be the main target of chloroquine, of which the
emergence of drug resistance is a major problem in controlling malaria
(8-10).
Histidine-rich proteins have been shown to function as heme polymerases
in vitro, and the best characterized of these proteins is
P. falciparum HRPII (or PfHRPII) (11-13). This protein has
been detected in the red cell as well as the fv, leading to the
suggestion that it is ingested from the red cell by the cytostome along
with hemoglobin and subsequently delivered to the fv. Early studies also suggest that resident fv proteases synthesized in a membrane-bound pro-form are transported to the PVM and then retrieved into the newly
developing cytostome, which ingests hemoglobin (11, 14). This has
rendered attractive a general model that both membrane and lumenal
components of food vacuole may be delivered to the PV and the red cell
from where they are internalized into the fv (5).
This is because (as indicated earlier) soluble proteins in the red cell
cytoplasm are not expected to be segregated. Yet whether cytosolic
antigens in the red cell can avoid ingestion has never been evaluated.
In mammalian cells and yeast, lumenal, resident proteases are thought
to be exported from the ER and sorted in the Golgi for transport to the
lysosomes and fv, respectively (15, 16), but to what extent this model
serves in lower eukaryotic pathogens like the malaria parasite is not known.
The function of HRPII in heme polymerization has been difficult to
evaluate in intact, infected red cells. Although the heme polymerase
activity (which is ascribed to the histidine-rich sequences of this
protein and other histidine-rich proteins and peptides) has been
demonstrated in vitro (11, 13), a laboratory cell line with
a natural deletion in HRPII and HRPIII can still produce hemozoin (11).
Thus, additional histidine-rich proteins may contribute to hemozoin
production. Our understanding has been further limited by the fact that
although there is evidence that PfHRPII is delivered to the infected
red cell cytosol and the fv as well as the extracellular medium, a
detailed characterization quantitating the distribution of the protein
and its transport properties has not been undertaken. Analysis of the
primary structure of HRPII using Signal P suggests an N-terminal signal
sequence and predicted cleavage site. However, the values for both are low, and this raises further questions of whether the protein is
efficiently recruited into the ER-Golgi secretory pathway in its
transport to diverse cellular destinations.
In this study, we have transfected P. falciparum-infected
red cells to express PfHRPII tagged with a C-terminal c-Myc epitope under continuous selection. Using high resolution microscopy and biochemical cell fractionation assays, we have characterized the distribution of the native protein and its Myc-tagged counterpart in
the parasite and the red cell to understand their functional consequences. The specific questions we asked were the following. (i)
Are PfHRPII and PfHRPIImyc exported to the red cell and subsequently endocytosed into the parasite or released across the red cell membrane?
(ii) Are PfHRPII and PfHRPIImyc detected within the parasite and the
fv? (iii) Are these proteins recruited into the secretory pathway, and
do cells expressing HRPIImyc show perturbations in secretory
organization, protein export to the red cell and/or the fv? (v) Do the
transformed cells show changes in heme polymerization and/or
sensitivity to chloroquine?
 |
MATERIALS AND METHODS |
Culturing of Parasites and Drug Treatments--
RPMI medium 1640 and A+ human serum were obtained from Invitrogen and Gemini
Biological Products (Calabasas, CA), respectively. Enhanced
chemiluminescence (ECL) reagents were from Amersham Biosciences. FITC-
or rhodamine-conjugated secondary antibodies were from Cappel, ICN.
Monoclonal mouse anti-c-Myc antibodies, 9E10, were purchased from Sigma. Antibodies to PfHRP II (HG12, 87) were obtained from Dr.
Diane Taylor. Monoclonal antibodies to PfPlasmepsin I were developed in
the Goldberg laboratory (17). Antibodies to PfBiP and PfERD2 were
developed in the Haldar laboratory. P. falciparum strains of
3D7, ACPGFP, and E8 were cultured in vitro by a
modification of the method of Trager and Jensen (18) and Haldar
et al. (19). To examine stage-specific events (from 6 to
42 h), parasites were synchronized to 4 h of growth using a
combination of Percoll purification and sorbitol treatments, cultured
to 10% parasitemia, and harvested at the indicated times. Parasite
growth was measured by examining Giemsa-stained blood smears and
hypoxanthine incorporation (20) into parasite DNA. Cell counts were
determined using a hematocytometer.
Plasmid Construction and Transfection--
The plasmid pHCHRP2m
was constructed as follows. HRP II open reading frame was
PCR-amplified by using primers
GCTCGAGATGGTTTCCTTCTCAAAAAATAAAGTATTATCCG and
GCAAGCTTAATGGCGTAGGCAATGTGTGGCGGC from P. falciparum
FCB total DNA, restricted with BamHI, and cloned into
SmaI-BglII-restricted pBSExp-1 to introduce c-Myc
epitope sequence at the 3' end. The insert was sequenced and then
recovered by XhoI digestion to clone into the plasmid pHC1
(a gift from Dr. Alan Cowman, Melbourne, Australia) to obtain pHCHRP2m.
The construction of the ACPGFP line has previously been described
(21).
Ring-infected red cells at a parasitemia of 10% were transfected with
Qiagen-purified supercoiled plasmid DNA by electroporation as described
by Fidock et al. (22) using Bio-Rad Gene pulser II with
settings of 0.31 KV and 950 microfarads. Forty-eight h after
transfection, pyrimethamine (Sigma) was added to the culture media and
maintained at a concentration of 100 ng/ml for 2 days. The
concentration of drug was subsequently reduced to 25 ng/ml and
maintained at 25 ng/ml. Parasites were cloned by serial dilution to
isolate pyrimethamine-resistant HRPII expressing P. falciparum E8 clone.
Immunolocalization Assays--
Infected red cells were attached
to poly-L-lysine-coated cover slips (20). Where
indicated, the cells were permeabilized in 0.01% saponin to release
red cell contents. Intact or permeabilized cells were subsequently
fixed with 1% paraformaldehyde for 10 min and permeabilized with
0.05% saponin for 20 min. The cells were incubated with 0.2% gelatin
for 30 min followed by incubation with primary antibodies and secondary
antibodies (diluted with PBS containing 0.01% saponin). Isolated fvs
were allowed to air dry and then were permeabilized with saponin and
probed with primary and secondary antibodies. Epifluorescence images
(30 optical sections of 0.2-mm thickness) were collected by DeltaVision
microscopy with a 100× oil objective (1.35 NA) attached to a cooled
charge-coupled device (CCD) camera. A series of single optical sections
were obtained, and the images were deconvolved on a SGI work station by
using SoftWoRx Version 2.5.
Preparation of Lysates for SDS-PAGE and Western
Blots--
Saponin permeabilization was carried out by mixing infected
erythrocytes with 10 volumes of 0.01% saponin followed by incubating at 4 °C for 10 min (this selectively lyses erythrocyte membrane, tubovesicular membrane (TVN), PVM but is expected to leave intact the
parasite plasma membrane). The saponin lysates were subjected to
centrifugation at 2,200 × g for 10 min, and the
supernatant (enriched in the erythrocyte cytosolic content) was
collected. The pellet containing isolated parasites was washed three
times with cold PBS. Supernatant and pellet fractions were assayed for glutamate dehydrogenase activity (by measuring the change in
A340 as a result of the conversion of NADPH to
NADP+ as described by Vander Jagt et al. (23))
to determine whether the parasite plasma membrane had ruptured or
parasites contaminated the supernatant fraction. Hypotonic lysates were
prepared by mixing infected cells with 10 volumes of water followed by
vigorous vortexing in the presence of protease inhibitors. The lysate
was subjected to centrifugation at 100,000 × g, the
supernatant and pellet fractions were collected. The samples obtained
after saponin treatment or hypotonic lysis were solubilized in 5 volumes of 1× SDS-PAGE sample buffer, boiled for 3-5 min, separated
by SDS-PAGE, and transferred to nitrocellulose filters. The filters
were incubated with 5% nonfat dry milk for 30 min and subsequently
incubated with either anti-HRPII antibody (1:1000) or anti-C-myc
antibody (1:500) for 1 h at room temperature. They were then
washed with Tris-buffered saline containing 0.05% Tween 20 and
incubated with peroxidase-conjugated secondary antibody (1:2000) for
1 h at room temperature. The bands were developed with ECL
solutions as per the manufacturer's protocol.
Quantitative Measurement of Hemozoin Content--
To release
hemozoin from parasites, infected cells were first lysed with 0.01%
saponin for 10 min at room temperature to release parasites from red
cell ghosts. The parasites were washed 3 times with PBS, resuspended in
2.5% SDS in PBS, and subjected to centrifugation at 20,000 × g for 1 h. The supernatant was discarded, and the insoluble pellet was washed again in 2.5% SDS in PBS and then dissolved in 20 mM NaOH. The hemozoin content was measured
by determining the absorbance at 400 nm and using a standard curve generated with hematin.
Food Vacuole Isolation--
Food vacuoles were isolated by the
method of Goldberg et al. (31). Briefly, cells were
harvested by centrifugation, washed 3× with PBS, resuspended in 5 volumes of 5% sorbitol, and incubated at room temperature for 20 min.
The lysate was centrifuged at 600 × g for 7 min. The
resulting supernatant was centrifuged at 2200 × g for
10 min and the pellet was treated with saponin and processed as
described by Goldberg et al. (31). The resulting lysate was
layered on top of a Percoll gradient. Isolated vacuoles were collected
from the bottom fraction. The fv enzyme plasmepsin I was used as a
marker for purification. Isolated fv fraction showed 10-fold enrichment
with a yield of 30%.
Biosynthetic Labeling of the Parasite and Analysis of
Metabolically Labeled Exported Proteins--
Red cells (1 × 109) infected with either 3D7 or E8 (15-20% parasitemia)
were washed twice with methionine-free RPMI and incubated in 10 ml of
PBS containing 4.5 mg/ml glucose and 500 µCi of
[35S]methionine-[35S]cysteine at 37 °C
for 2 h. The cells were collected by centrifugation and washed 3 times with PBS at 4 °C. The cells were lysed with 0.01% saponin at
room temperature for 10 min and subject to centrifugation at 2200 × g for 10 min. The supernatant (red cell cytosol) was saved and processed for SDS-PAGE. The gel was dried and exposed to film
to analyze the pattern of exported proteins in the different lines.
Flow Cytometry--
1-2 × 108 cells
from E8 or 3D7 cultures were washed in PBS and fixed in 1%
formaldehyde in PBS for 15 min. Excess aldehyde was removed, and the
cells were incubated with anti-HRPII antibody for 30 min followed by
FITC-conjugated secondary antibody for 30 min. The parasite nuclei were
stained with propidium iodide (10 µl/ml). Where indicated, after
fixation the cells were permeabilized by treatment with 0.05% saponin
for 20 min and subsequently processed for antibody binding. Samples
were analyzed on a BD PharMingen FACScan (FACSCALIBUR). Data was
analyzed with CELLQuest software, and fluorescence histograms and dot
plots were displayed on a four-decade logarithmic scale.
Transmission Electron Microscopy--
E8-infected red cells were
fixed in a mixture of 2% glutaraldehyde, 1% tannic acid, and 4%
sucrose in a 0.05 M phosphate buffer, pH 7.4, for 2 h
and post-fixed in 1% osmium tetraoxide for 1 h. Samples were then
block-stained in 0.5% aqueous uranyl acetate, dehydrated in ascending
concentrations of ethanol, and embedded in Epon 812. Ultrathin sections
were stained with 2% uranyl acetate in 50% methanol and lead citrate
and examined in a Zeiss CEM902 electron microscope (Oberkochen, Germany).
Field Emission in-lens Scanning Electron Microscopy
(FEISEM)--
Samples were prepared for FEISEM as described by Chen
et al. (25).
Before sample application, 5 × 5-mm silica chips (Ted Pella,
catalog #16008) were cleaned with ethanol, coated with polylysine, and
then rinsed three times with distilled water. One-three nmol of heme
polymer were applied onto chips in distilled water. After centrifugation at 3000 × g for 10 min, heme crystals
formed a thin layer on chip surfaces. Chips were then stained with 2%
uranyl acetate for 30-60 min. After one quick rinse with 50% ethanol, chips were rinsed consecutively in 50, 70, and 90% ethanol for 3 min
each. After critical point drying for 1-2 h, chips were coated with
chromium. Silica chips loaded with samples were ready for field
emission in-lens scanning electron microscopy (LEO 1550)
 |
RESULTS |
Characterization of the Expression and Distribution of Endogenous
PfHRPII in the Parasite and the Red Cell during Asexual
Development--
Plasmodium infection of red cells begins
with the intracellular "ring" stage that lasts for the next 24 h. The parasite then matures through a second, morphologically distinct
trophozoite stage (24-36 h) to enter the terminal stages of
schizogony, where mitosis occurs and daughter merozoites assemble
(36-48 h). At the end of schizogony, the infected red cells lyse to
release merozoites (into the extracellular medium) that re-invade
erythrocytes and thereby maintain the asexual cycle (Fig.
1). As previously shown (11, 13, 26),
endogenous PfHRPII is detected in the infected erythrocyte cytoplasm of
ring and schizont stages (Fig. 2A). Western blots also
indicate that the protein is expressed in 12-h ring stage parasites and
largely maintained through the trophozoite stage and in schizonts (Fig.
2B); however, northern blots show that HRPII RNA is present
only in ring stages (Fig. 2C). This suggests that after
24 h, trophozoites and schizonts do not synthesize PfHRPII
de novo, and most of the protein made in rings remains
associated with these later stage parasites and are not transported to
the extracellular medium.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Asexual life cycle of P. falciparum in red cells. Infection of the red
cell is initiated by the extracellular merozoite, which then develops
through morphologically distinct ring, trophozoite, and schizont
stages. Plasmodium parasites (P) develop within
the parasitophorous vacuole (white) that resides in the
erythrocyte. The PVM is connected to a tubovesicular membrane
(TVN) network of nutrient transport. Hemoglobin (light
gray) is delivered to the fv by the formation of a double-walled
cytostome. Active ingestion of hemoglobin and hemozoin (hz)
production is maximal at the late ring and trophozoite stages and is
completed by schizogony. Other soluble proteins (including parasite
antigens exported to the red cell), indicated by black dots,
are also expected to be delivered to the fv by this pathway.
N represents the nucleus. PPM, parasite plasma
membrane
|
|

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 2.
Expression and distribution of PfHRPII in
non-transformed 3D7-infected red cells. A,
ring-infected (0-12 h) and trophozoite-infected (24-36 h)
erythrocytes were fixed, permeabilized, and probed with anti-HRPII
antibody followed by FITC-conjugated secondary antibody in indirect
immunofluorescence assays, stained with Hoechst dye to visualize
parasite nucleus, and imaged by DeltaVision (see "Materials and
Methods"). Fluorescence from only the FITC channel is shown. The
scale bar is in µm. N indicates the position of
parasite nuclei. B, 2 × 106-infected red
cells (as determined by independent cell counts) were removed at the
indicated times of growth from synchronized cultures and subjected to
Western blotting using anti-HRPII antibody. C, i,
Northern blot of RNA (isolated with TRIzol per the manufacture's
instruction) from synchronized parasites harvested at the indicated
times and hybridized with a HRPII (1 kilobase (kb)) probe.
ii, the corresponding RNA gel loaded with 5 µg of
indicated RNAs and molecular size markers. D,
trophozoite-infected red cells were lysed with 0.01% saponin. 2 × 106 parasite equivalents of the supernatant
(S) and parasite pellet (P) fractions were
prepared for SDS-PAGE and Western blots (see "Materials and
Methods") and probed for PfHRPII (i), assayed for
glutamate dehydrogenase (GDA) activity (ii), or
probed for PfBiP (see "Materials and Methods") (iii).
E, densitometric analyses of Western blots indicating HRPII
protein detected in saponin supernatant (i) or pellets
(ii) at different times of parasite growth.
|
|
To examine what fraction of the total, cell-associated PfHRPII protein
is exported from the parasite, we lysed synchronized, trophozoite-infected red cells (30-33 h; which express maximal levels
of HRPII) with 0.01% saponin (Fig. 2D, i). As
shown, 97% was found in the supernatant fraction. This treatment does
not release the parasite cytosolic enzyme glutamate dehydrogenase (Fig.
2D, ii), confirming that the parasite plasma
membrane is intact and is consistent with previous studies that saponin
selectively perforates the red cell membrane and the PVM but not the
parasite plasma membrane (23, 27). The secretory marker PfBiP is also not released, as expected if the parasite plasma membrane is intact (Fig. 2D, iii). Together these data show that by
the trophozoite stage (30-33 h) the vast majority of HRPII is exported
from the parasite to the red cell.
A time course of export from the parasite shown in Fig. 2E,
i, indicates that most of the export is achieved by the late
ring (24 h) stage. 90% of this exported protein can be detected at schizogony (>36 h). The experimental error (due to variation in cell
counts and low levels of cell loss at schizogony) is 10%, suggesting
that the levels of exported protein essentially do not change after
24 h of development. That there is no new synthesis of protein
after 24 h suggests that PfHRPII exported to the red cells does
not undergo bulk endocytic uptake into the parasite throughout
trophozoite development, although greater than 80% of the hemoglobin
is ingested and digested during this time (Refs. 5 and 28 and data not
shown). However, a small but constant amount of HRPII that corresponds
to 3% of total trophozoite protein associates with the pellet fraction
throughout asexual parasite growth (Fig. 2E, ii),
suggesting that there are mechanisms to retain a minor portion of
PfHRPII in the parasite. Because the total levels of cell associated
protein remain constant over time, the data in Fig. 2 argue against
significant release of HRPII into the extracellular medium until the
infected red blood cell ruptures. An early report (26) suggests that a
histidine-labeled form of HRPII is exported into the extracellular
medium. However definitive evidence obtained by combining short pulse
times with appropriate chase times and quantitative
immunoprecipitations were not provided. This makes it difficult to
evaluate how much of the export detected was due to partial cell lysis.
Pulse-chase studies are difficult to undertake with PfHRPII because the
protein is methionine-poor and, thus, cannot be metabolically labeled with [35S]methionine with any efficiency.
Expression of a Transgene PfHRPIImyc during Asexual
Development--
To further examine the relationship between the
exported and parasite-associated pools of protein, we expressed in
trans-PfHRPII tagged at its C terminus with Myc (see Fig.
3A) under the
cam promoter using the pHC1 plasmid to establish the
transformed E8 line (see "Materials and Methods"). Our unpublished
studies suggested that cam is active at the trophozoite
stage (data not shown). Western blots (Fig. 3B) show that
the expression of Myc-tagged HRPII protein in transformed E8 cells is
detectable in 18-h rings. Low levels of HRPIImyc are also expressed in
12-h rings and can be detected in single cells by immunofluorescence
assays (Fig. 3A, ii) or by loading 2 × 107 or more of parasite material in Western blots (data
not shown). Northern analysis (Fig. 3C) using a 1-kilobase
(kb) probe that detects HRPII RNA shows that transformed
cells contain higher levels of message in the trophozoite and schizont
stages compared with rings. By the (33-36 h) trophozoite stage, 85%
of PfHRPIImyc is released by saponin treatment under conditions where
parasite glutamate dehydrogenase and BiP are not released (Fig. 3,
D and E). There is some reduction in the fraction
released when higher levels of transgene are expressed at later times
(>40 h). The reasons for this are unclear. However, because high
levels of trans gene expression may be harmful to cells,
subsequent analyses of transfected cells was restricted to 33-h
trophozoites.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of PfHRPIImyc and total PfHRPII
levels in transformed E8-infected cells. A, i, a
schematic of plasmid pHC1-HRP2m. Arrowheads indicate the
direction of transcription. Restriction sites: B is
BamHI; H is HindIII; K is
KpnI; X is XhoI. HRPII expression is
driven by the P. falciparum cam 5'-untranslated
region (5'-PcDT). Tgdhfr-ts is driven by the
Plasmodium chabaudi dhfr-ts 5'-untranslated
region. A, ii, ring-infected (0-12 h) and
trophozoite-infected (24-36 h) red cells were fixed, permeabilized,
and probed with either anti-HRPII antibody or anti-Myc antibody and
FITC-conjugated secondary antibodies in indirect immunofluorescence
assays, stained with Hoechst, and imaged by DeltaVision (see
"Materials and Methods"). Fluorescence from the FITC channel is
shown. The scale bar is in µm. N indicates the
nucleus. B, 2 × 106 of synchronized E8-
and 3D7-infected red cells were probed with (i and
iii) anti-Myc antibody or (ii) anti-HRPII
antibody. C, i, Northern blot of RNA (isolated
with TRIzol per the manufacturer's instruction) from synchronized
parasites harvested at the indicated times and hybridized with a HRPII
(1 kilobase (kb)) probe. ii, corresponding RNA
gel loaded with 5 µg of indicated RNAs and molecular size markers.
D, 2 × 106 trophozoite stage E8-infected
red cells were permeabilized with 0.01% saponin. Supernatant
(S) and pellet (P) fractions were probed in
westerns with anti-PfHRPII (i) anti-c-Myc (ii),
or anti-PfBiP (iv) or assayed for glutamate dehydrogenase
activity. E, densitometric analyses of Western blots
indicating HRPII protein detected in saponin supernatant (open
diamonds), pellets (open circles), or intact cells
(open squares) from the E8 strain at different times of
parasite growth.
|
|
A comparison of total HRPII protein in parent 3D7 and transformed E8
lines during intraerythrocytic development undertaken in Fig.
4A (where
samples were run on the same gels and processed simultaneously) shows
that rings may contain lower levels of the transgene product. However,
as the parasites develop into trophozoites (up to 33 h), there is
3-4-fold more total HRPII protein in transformed cells; schizonts
(>36 h) contain even higher levels. Transformed trophozoites release
3-4-fold more HRPII protein into the saponin supernatant (Fig.
4B). This closely reflects elevated levels of protein
expression in these cells and suggests that, like its endogenous
counterpart, PfHRPIImyc is primarily exported out of the parasite into
red cell cytoplasm and remains there, even when 80% of the hemoglobin
is ingested by the parasite.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 4.
Comparative analyses of the distribution
total PfHRPII protein in E8-and 3D7-infected red cells.
A, densitometric analysis of the expression of total HRPII
protein detected at different times of growth. B,
densitometric analyses of the distribution of total HRPII protein in
saponin supernatant and parasite. *, level of HRPII in the parasite
fraction of 3D7 cells is 0.006 arbitrary units. C, infected
red cells were subjected to hypotonic lysis; supernatant (S)
and pellet (P) fractions were prepared (see "Materials and
Methods") and assayed for HRPII protein. 5 × 106
parasite eq from supernatant and pellet fractions were analyzed, and
blots were quantitated by densitometric analysis (see "Materials and
Methods"). D, trophozoite-infected (24 h) red cells were
fixed, permeabilized, and probed with anti-HRPII antibody followed by
FITC-conjugated secondary antibody in indirect
immunofluorescence assays, stained with Hoechst, and imaged by
DeltaVision (see "Materials and Methods"). Fluorescence from the
FITC channel of three 200-nm optical sections reflects protein
distribution from the center (section 20) to the periphery
(section 4) of the infected red cell. P indicates
parasite. E, flow cytometry analysis of 3D7- and E8-infected
red cells stained with anti-HRPII antibody. I and
II, intact infected red cells were fixed with formaldehyde
and then stained with antibody. III and IV,
infected red cells were fixed and subsequently permeabilized with
saponin and stained with HRPII. In non-permeabilized samples
(I and II), the bulk of the late parasites
(quadrants a and b) and ring-infected cells
(quadrants c and d) stain for HRPII at similar
levels as uninfected cells (quadrants e and f).
Inset, histogram showing the distribution of uninfected and
infected red cells.
|
|
The release of HRPII and HRPIImyc into saponin-sensitive supernatant
fractions suggested that they are soluble proteins in the erythrocytic
milieu. However, saponin can intercalate with lipids like cholesterol
and may, therefore, affect some forms of protein-membrane association.
Thus, to determine what fraction of HRPII in 3D7 and E8 cells are
soluble, we subjected cells to hypotonic lysis followed by
centrifugation at 100,000 × g. As shown (Fig.
4C), 90 and 80% of HRPII appears to be soluble in the 3D7
and E8 cells, respectively. That 97 and 90% are, respectively, exported argues that the bulk of exported PfHRPII protein in both cell
lines is soluble. However, a low fraction 10-20% may have a
peripheral association with membranes. In addition, examination of
consecutive optical sections through the depth of the infected red
cells shows that most of the exported protein is detected in sections
at the periphery of the red cell (Fig. 4D). In contrast in
intermediate sections, the signal is not prominent in the red cell.
Thus, it is possible that HRPII and HRPIImyc may not freely diffuse
through the red cell cytoplasm but may concentrate primarily at the
periphery of the red cell and, thus, avoid ingestion along with hemoglobin.
PfHRPII and PfHRPIImyc Are Not Transported across the
Trophozoite-infected Red Cell Surface--
As indicated earlier, one
previous study has proposed that at the trophozoite stage, HRPII is
secreted across the red cell membrane into the extracellular medium
(26). Our present data (Figs. 2B and 3B) suggest
that although HRPII protein is not quantitatively released from 3D7 or
E8 cells, it localizes to the periphery of the red cells; thus, some
fraction of the protein could be on the infected red cell surface. To
address this we examined both parent and transformed lines for HRPII
associated with the infected cell surface by flow cytometry (Fig.
4E). This is a highly sensitive method for protein
determination on single cells as well as in a population. Infected
erythrocytes can be distinguished from their uninfected counterparts by
staining for parasite DNA, and as shown in the insets in
Fig. 4E, panels I and II, a peak
(i) and intermediate shoulder (ii) followed by a
second peak (iii) correspond to separation of uninfected,
ring-infected, and trophozoite-/schizont-infected (late stage
parasites) cells. In non-permeabilized samples (panels I and
II), the bulk of the late stage parasites (quadrants
a and b) and ring-infected cells (quadrants
c and d) stain for HRPII at similar levels as
uninfected cells (e and f). A very small fraction
(about 1%) of the late stage parasite-infected erythrocytes in E8
(quadrant b panel II) appear to show increased cell surface fluorescence; this is not seen in the parent line. The reasons for this
are unclear; one possibility is that there is a small population of
contaminating terminal schizonts that are about to rupture and
release high levels of the trans gene product. However, for
99% of the red cell population infected with either late stage 3D7 or
E8, no fluorescence was seen at the surface. In contrast, infected red
cells permeabilized with saponin show high levels of PfHRPII staining
(panels III and IV). The numbers of uninfected
red cells in panel III and IV are
disproportionately low because despite fixation, saponin-permeabilized
uninfected red cells are not quantitatively recovered after
centrifugation at 3000 × g (see "Materials and
Methods"). Nonetheless panels III and IV
demonstrate that the anti-PfHRPII antibody used in panels
I-II indeed recognizes HRPII protein in this assay. Thus, the
failure to detect quantitative cell surface expression in panels
I and II suggests that neither HRPII nor HRPIImyc are
exported to the infected red cell surface (the 3-fold increase in total PfHRPII levels in E8 cells compared with 3D7 cells are obscured by the
log scale (conventionally) used in flow cytometry measurements shown in
Fig. 4E).
Both HRPII and HRPIImyc Are Recruited into the Secretory Pathway;
Elevation of Total HRPII Protein Levels within Transfected Parasites
Has No Effect on Protein Export from the Parasite--
To confirm that
HRPII is recruited to the secretory pathway we examined the
distribution of protein in cells treated with the drug brefeldin A
(BFA) that blocks secretory export from cells. An unexpected feature of
rings of P. falciparum is that extended treatments for
24 h or longer are entirely reversible, in that washing BFA out
completely restores parasite protein export (27). This unusual feature
enables examination of the effects of this secretory block on long term
protein accumulation as rings progress to the trophozoite stage. As
shown, in Fig. 5A, in the
presence of BFA, all cell-associated HRPIIs detected in both E8 and 3D7 reside within regions that stain with the ER marker PfBiP. This suggests that both endogenous and transgenic proteins are recruited to
the ER; that they accumulate in a small region of PfBiP stain in the
presence of BFA is consistent with previous results that the drug
probably restricts secretory proteins to a region of the ER. Removal of
BFA by washing completely restored HRPII and HRPIImyc export (data not
shown).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 5.
Comparative analysis of secretory recruitment
of HRPII, export of parasite proteins in E8- and 3D7-infected
erythrocytes, and distribution of total PfHRPII, PfHRPIImyc, plasmepsin
I, and BiP in parasites and isolate food vacuoles. A,
ring-infected red cells from E8 and 3D7-strains were treated with
brefeldin A, stained for PfBiP (red), PfHRPII
(green), and Hoechst dye (blue) in indirect
immunofluorescence assays, and imaged using DeltaVision (see
"Materials and Methods"). Single optical sections showing a merge
of red and green as yellow are shown.
B, metabolically labeled parasite proteins detected in the
supernatant fractions of trophozoite stage 3D7- and E8-infected red
cells treated with 0.01% saponin (see "Materials and Methods")
were analyzed by SDS-PAGE and fluorography. C, FEISEM of
heme polymer purified from 3D7 and E8 parasites. D, 10 µg
of protein from isolated parasites or isolated food vacuoles from E8
and ACPGFP cells were subjected to SDS-PAGE and probed in Western blots
for HRPII, c-Myc, plasmepsin I, HRPII, and BiP. E, isolated
vacuoles from E8 (i and iii) and ACPGFP
(ii) cells were probed with anti-HRPII (green) or
anti-c-Myc (red) (i-ii) or anti-plasmepsin I
(green) and anti-ERD2 (red)
(iii).
|
|
As previously shown (in Fig. 4B) transgenic parasites
contain ~10-fold higher levels of PfHRPII within the parasite
compared with non-transformed cells. Because the trans gene
product is recruited into the secretory pathway, elevation of protein
within the parasite could in principle affect secretory functions of the organism. However, as shown in Fig. 5B, accumulation of
the trans gene product had no significant effect on the
export of metabolically labeled parasite proteins as measured by
SDS-PAGE or acid-insoluble counts (not shown). This suggests that
PfHRPIImyc expression does not alter general biosynthetic protein
export from the parasite. Furthermore, ultrastructural studies by
electron microscopy and indirect immunofluorescence assays (not shown) confirm that in E8 cells there are no detectable changes in secretory membrane organelles, including secreted compartments such as clefts and
loops induced in the red cells as well as the ER-Golgi, parasite plasma
membrane, and PVM, which have been implicated in protein export
pathways. Thus, although it is recruited into the secretory pathway and
found at higher levels within the parasite, trans-expressed PfHRPIImyc has no prominent effect on ultrastructural organization of
the parasite or bulk protein export to the red cell.
Effects of PfHRPIImyc Expression on Hemozoin Production and
Chloroquine IC50--
Because PfHRPII is proposed to be a
heme polymerase, we investigated whether hemozoin levels as well as
chloroquine sensitivity were altered in transfected cells. In 33-h
parasites there is ~26% reduction in hemozoin in the transformed E8
line compared with parent 3D7 cells. To control for transfection we
also examined a second transfected line expressing a secretory
transgene ACPGFP. This gene is not histidine-rich nor is it delivered
to the fv. Rather, as shown by Waller (29) and our work (30), it is
targeted to another secretory organelle called the apicoplast. The
ACPGFP cells show a 30% reduction in growth (measured by incorporation of hypoxanthine into DNA), a 10% reduction in hemozoin, and a 17% reduction in chloroquine sensitivity. This suggests that
trans gene expression contributes to a decrease in cell
growth (probably due to the cost of carrying the resistance plasmid),
which in turn reduces hemozoin production. E8 cells also show a 30%
reduction in growth (as measured by hypoxanthine incorporation), which
is expected since they express a transgene. However, there is a 26% reduction in hemozoin and a 30% reduction in chloroquine sensitivity. Because hypoxanthine incorporated by E8 and ACPGFP cells is comparable, a 16% reduction in hemozoin and a 13% reduction of chloroquine sensitivity of E8 cells cannot be ascribed to transfection per se. The two cell lines were maintained at the same concentration of drug and processed simultaneously so the difference in hemozoin content and chloroquine sensitivity is not expected to be due to other
global effects and assay variation. This suggests that trans
expression of PfHRPIImyc can influence hemozoin levels in the fv.
However, the elevation of PfHRPII levels did not change the
three-dimensional structure of the hemozoin crystals (Fig. 5C) formed in E8.
Effects of PfHRPIImyc Expression on Association of Secretory
Markers in Isolated fv--
The observed reduction in hemozoin
production in E8 cells led us to investigate the association of HRPII
and HRPIImyc with isolated fv. A biochemical analysis with isolated fv
was undertaken to facilitate quantitative estimation of marker
association with the vacuoles. These fv preparations have been
previously characterized to show that they are enriched in resident
proteases but relatively depleted in other cellular proteinases (31,
33). They are isolated from trophozoite-stage (24-36 h) parasites,
because this is the time of active hemozoin production. The resident fv
protein plasmepsin I (global) was used as the marker for purification (24).
Shown in the Western blot in Fig. 5D is the distribution of
HRPII and fv proteins detected in parasites and fv isolated from ACPGFP
and E8 cells. To provide a quantitative estimation, we loaded equal
amounts (10 µg) of protein from (i) isolated parasites and (ii)
isolated vacuoles. Densitometric analysis indicates that both E8 and
ACPGFP cells produce comparable levels of plasmepsin I and BiP. Yet
there was a 10-fold enrichment of plasmepsin I in isolated vacuoles
from ACPGFP. Because the same amount of protein was loaded in each
lane, this 10-fold reduction cannot be due to a lower number of fvs in
the E8 sample. By indirect immunofluorescence, isolated fvs from E8
parasites can be stained with antibodies to plasmepsin I (the marker
for fv purification) and c-Myc but not the Golgi marker PfERD2 (Fig.
5E). Vacuoles from the ACPGFP line fail to show Myc
expression. These data show that the vacuole preparation is indeed
enriched for isolated fv; moreover, these vacuoles contain HRPII and
HRPIImyc. However, the total amount of HRPII signal associated with E8
vacuoles is comparable with that seen for ACPGFP vacuoles even though
the latter parasites have 10-fold less total HRPII protein than E8
cells. In addition, although E8 parasites express comparable levels of
plasmepsin I relative to ACPGFP cells, the amount of plasmepsin I seen
in vacuoles isolated from E8 parasites is much reduced. One explanation is that the efficiency of transporting both PfHRPII and plasmepsin I to
the fv is reduced in E8 cells.
As shown in Fig. 5D, in addition to being enriched for food
vacuole enzymes like plasmepsin I, isolated vacuoles from ACPGFP cells
also concentrate the ER marker PfBiP. This suggests that PfBiP may be
transported to the fv. Alternatively its presence may reflect a
contamination of ER membranes in fv preparations. However, if it were a
contaminant, comparable levels of BiP would be expected to associate
with fv isolated from E8 and ACPGFP cells, since the difference in
total levels of BiP between these parasites is less than 2-fold.
Instead BiP is markedly decreased in fvs isolated from E8 cells. It is
important to note that BiP is not released into the red cell cytosol
(see Figs. 2 and 3), suggesting that BiP does not "leak" out
throughout the secretory pathway. Moreover, as indicated earlier, the
Golgi marker PfERD2 is not found in isolated fv (see Fig. 5E
and data not shown). Thus, the association of PfBiP with isolated fv is
not expected to be due to contamination by secretory membranes but
could reflect an ER to fv transport pathway that is disrupted in E8 cells.
To determine the major sites of secretory accumulation of HRPII and
plasmepsin I within E8 parasites, we permeabilized infected red cells
to release HRPII from the cytosol and then examined the distribution of
these proteins relative to other secretory markers. High
resolution-digitized fluorescence microscopy (Fig. 6A) show that HRPII and
plasmepsin I show substantial colocalization with PfBiP in E8 cells but
not markers of the Golgi (ERD2) or the parasite plasma membrane (not
shown), consistent with the idea that HRPII and plasmepsin I are
blocked in the ER in E8 cells and could be substrates in an ER to fv
pathway. Upon hypotonic lysis and centrifugation, all of the HRPII
protein in E8 parasites is found in the pellet fraction, suggesting
that both ER and fv forms associate with membranes (Fig.
6B). HRPII in ACPGFP parasites is also in the pellet
fraction (Fig. 6B), suggesting that membrane association
within the parasite is not a consequence of HRPII transgene expression.
Its membrane association and, likely, ER location suggests that PfHRPII
in E8 parasites is probably not derived by endocytic uptake of soluble
PfHRPII delivered to the red cell.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Membrane association of parasite-HRPII in E8
and ACPGFP cells. A, 30-33-h trophozoite-infected red
cells from 3D7 and E8 strains were attached to
poly-L-lysine-coated cover slips and then permeabilized
with 0.01% saponin to release the erythrocytic contents. The adherent
cells were then fixed with formaldehyde and probed for the distribution
of the indicated proteins by indirect immunofluorescence microscopy
(see "Materials and Methods"). B, saponin pellets were
subjected to hypotonic lysis, and supernatant (S) and pellet
(P) fractions were prepared and subjected to Western blots
using anti-HRPII and anti-GFP antibodies (see "Materials and
Methods").
|
|
 |
DISCUSSION |
Our studies suggest that both PfHRPII and PfHRPIImyc are stable
proteins that are exported to the red cell and the fv. 3-4-Fold elevation of PfHRPIImyc expression results in a corresponding increase
in total HRPII release into the red cells but no increase of HRPII
protein in the fv. This strongly argues against HRPII undergoing bulk
endocytosis with hemoglobin. Moreover most of the protein detected in
the E8 parasites shows secretory accumulation in the ER, and it is
unlikely that this is a consequence of endocytosis. This raises the
question of how HRPII exported to the red cell is excluded from
endocytic uptake during the ingestion of hemoglobin. It is possible
that hemoglobin exists as a dense semi-crystalline state in the red
cells that excludes parasite proteins (such as HRPII and HRPIImyc) in
the periphery of the red cells. Alternatively, PfHRPII may actively
segregate. The reason for the punctuate staining of PfHRPII and
PfHRPIImyc is not clear but could underlie protein-protein interactions
that contribute to their exclusion from hemoglobin. Although the
precise mechanisms are not known, our data provide the first evidence
that an antigen released into the red cell can "sort" away from
hemoglobin, concentrate in the periphery of the red cell, and need not
undergo bulk digestive uptake into the fv (see Fig.
7, a model). Thus membrane-bound
intermediates may not be required to deliver soluble antigens to the
edge of the red cell. This is in marked contrast to the idea that
soluble proteins exist in an unsorted mixture in the cytoplasm of a
mammalian cell and suggests that cytosolic protein-protein interactions in the absence of membrane may have important implications for eukaryotic cellular transport pathways in general and digestive uptake
in Plasmodium in particular.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 7.
Model of HRPII transport to erythrocyte
cytosol and fv. Newly synthesized HRPII is recruited into the ER
and either exported as soluble protein (97%) or retained in a
membrane-associated (3%) form. Soluble HRPII sorts in the periphery of
the red cell and is not ingested into the parasite with hemoglobin. The
membrane-associated HRPII is transported directly to fv from the ER
together with other parasite proteins such as plasmepsin I and PfBiP.
The tubovesicular network that extends from the parasitophorous vacuole
to the red cell is not shown. PV is parasitophorous
vacuole.
|
|
A C-terminal c-Myc epitope does not significantly interfere with
recruitment of HRPII into the secretory pathway, its export from the
parasite, or its residence in the red cell. Further significant extracellular release of PfHRPII or PfHRPIImyc does not occur during
the first 36 h of intraerythrocytic development. BFA treatment appears to result in protein accumulation in a region of the ER. The
trans gene is maximally expressed and exported at the
trophozoite and schizont stages, whereas the endogenous protein is
exported at the ring stage. This suggests that unlike transport to
apical organelles (32), protein secretion to the red cell is not
temporally regulated. This argues against a "secondary ER" that has
been proposed to exist as a specialized compartment in
Plasmodium dedicated to ring stage export to the erythrocyte
(33).
Both HRPII and HRPIImyc are also transported to the fv. However,
because the bulk of both proteins is delivered to the red cell and
remains there, it is reasonable to presume that transport of HRPII to
the fv is not due to the presence of a specific targeting signal on
these proteins. Rather, transport there may depend on interactions with
other proteins; a functional consequence of these interactions may
underlie reduced transport of plasmepsin I and BiP to the fv in E8
cells. That BiP along with plasmepsin I is enriched in isolated fvs,
suggests that there may be an ER to fv transport pathway. Because BiP
is also not expected to contain peptidic signals for transport to the
fv, it is likely to be delivered as a complex with other (signal
bearing) proteins (such as plasmepsin I), consistent with its function
as a chaperone. One possibility is that in addition to its
resident-targeting signals, plasmepsin I may complex with BiP for
optimal transport to the fv. If newly synthesized HRPII associates with
plasmepsin I-BiP complex, it could piggyback into the fv (see Fig. 7).
HRPIImyc is delivered to the fv and affects BiP association with the
fv, suggesting that it too may use a biosynthetic ER-fv pathway.
Biosynthetic pathways of transport to digestive organelles that are
independent of endocytic routes have been demonstrated in eukaryotes
(34). However proteins are targeted from the Golgi to the yeast vacuole or mammalian lysosomes (35). Transport from the ER to the fv may
reflect an unstacked Golgi (decreasing the need for stepwise transport
through this organelle) during ring and trophozoite stages of
Plasmodia (36) and argues that in primitive eukaryotes the
ER may combine both biosynthetic and sorting functions.
How is PfHRPII/HRPIImyc shunted off to the fv pathway differentiated
from that exported from the parasite? The fv and secretory forms of the
proteins within the parasite are membrane-associated, whereas the
exported forms are largely soluble. Because the endogenous HRPII within
the parasite is also membrane-associated, the higher level of HRPII
associated with E8 parasites is not catalyzed by c-Myc per
se but could be due to higher levels of trans gene
expression. Treatment with EDTA releases HRPII and HRPIImyc from the
membrane (not shown), suggesting that it may require divalent cations
such as calcium that are elevated in the ER. In E8 cells, elevated levels of newly synthesized, membrane-bound PfHRPIImyc in the ER may
compete BiP away from membrane-associated plasmepsin I, leading to a
reduced efficiency of fv transport for all three components.
Recent studies estimate that 1.2 µM PfHRPII in the fv
would be sufficient to catalyze heme polymerization in the fv (13). Our
present studies showing that a maximum of 3% of endogenous PfHRPII is
retained in the parasite would suggest that micromolar concentrations
of the protein are probably not achieved in the fv. Furthermore, it is
known that loss of HRPII and HRPIII does not prevent heme
polymerization in cells (11). Our data that a vast majority of
endogenous HRPII and a trans gene are exported to the red
cell cytoplasm and remain there suggest that a major function of this
protein is likely to be at its principal site of residence, in the
periphery of the red cell or in its released form after host cell
rupture. That soluble HRPII can sort away from hemoglobin and that
secretory, membrane-bound HRPII can disrupt protein transport to the fv
may reflect protein-sorting properties of PfHRPII that underlie novel
mechanisms of protein targeting in the red cell and food vacuole of
this major human pathogen. Our data also suggest a direct ER to fv
transport pathway and a sorting function for the ER in a eukaryotic cell.
 |
ACKNOWLEDGEMENT |
We thank Dr. Diane Taylor for the generous
gift of PfHRPII antibody.
 |
FOOTNOTES |
*
This work was supported by National Institutes
of Health Grants AI26670 and HL69630 (to K. H.) and AI47798 (to
D. E. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of Burroughs Wellcome Scholar Award in Molecular Parasitology.

Recipient of Burroughs Wellcome Career Award and a Pew Scholar Award.
§§
Recipient of Burroughs Wellcome New Initiatives in Malaria Award.
To whom correspondence should be addressed. Tel.: 312-503-0224; E-mail:
k-haldar@northwestern.edu.
Published, JBC Papers in Press, May 22, 2002, DOI 10.1074/jbc.M201968200
 |
ABBREVIATIONS |
The abbreviations used are:
PVM, parasitophorous
vacuolar membrane;
fv, food vacuole;
HRPII, histidine-rich protein II;
PfHRPII, P. falciparum HRPII;
ER, endoplasmic reticulum;
FITC, fluorescein isothiocyanate;
PBS, phosphate-buffered saline;
BFA, brefeldin A;
ACPGFP, acyl carrier protein-green fluorescent protein;
FEISEM, field emission in-lens scanning electron microscopy;
BiP, luminal binding protein.
 |
REFERENCES |
| 1.
|
Walsh, J. A.
(1989)
Ann. N. Y. Acad. Sci.
569,
1-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Holder, A. A.
(1996)
in
Mararia Vaccine Development: A Multi-immune Response and Multi-stage Perspective
(Hoffman, S. L., ed)
, pp. 77-104, American Society for Microbiology, Washington, D. C.
|
| 3.
|
Gratzer, W. B.,
and Dluzewski, A. R.
(1993)
Semin. Hematol.
30,
232-247[Medline]
[Order article via Infotrieve]
|
| 4.
|
Deitsch, K. W.,
and Wellems, T. E.
(1996)
Mol. Biochem. Parasitol.
76,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Goldberg, D. E.
(1993)
Semin. Cell Biol.
4,
355-361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Fitch, C. D.,
and Kanjananggulpan, P.
(1987)
J. Biol. Chem.
262,
15552-15555[Abstract/Free Full Text]
|
| 7.
|
Slater, A. F.,
Swiggard, W. J.,
Orton, B. R.,
Flitter, W. D.,
Goldberg, D. E.,
Cerami, A.,
and Henderson, G. B.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
325-329[Abstract/Free Full Text]
|
| 8.
|
Moran, J. S.,
and Bernard, K. W.
(1989)
J. Am. Med. Assoc.
262,
245-248[Abstract]
|
| 9.
|
World Health Organization.
(1990)
Trans. R. Soc. Trop. Med. Hyg.
84 Suppl. 2,
1-65[Medline]
[Order article via Infotrieve]
|
| 10.
|
World Health Organization, Division of Control of Tropical Diseases.
(1996)
Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas of Intense Transmission, WHO/MAL/96.1077
, World Health Organization, Geneva
|
| 11.
|
Sullivan, D. J., Jr.,
Gluzman, I. Y.,
and Goldberg, D. E.
(1996)
Science
271,
219-222[Abstract]
|
| 12.
|
Tyas, L.,
Gluzman, I.,
Moon, R. P.,
Rupp, K.,
Westling, J.,
Ridley, R. G.,
Kay, J.,
Goldberg, D. E.,
and Berry, C.
(1999)
FEBS Lett.
454,
210-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Papalexis, V.,
Siomos, M. A.,
Campanale, N.,
Guo, X.,
Kocak, G.,
Foley, M.,
and Tilley, L.
(2001)
Mol. Biochem. Parasitol.
115,
77-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Francis, S. E.,
Gluzman, I. Y.,
Oksman, A.,
Knickerbocker, A.,
Mueller, R.,
Bryant, M. L.,
Sherman, D. R.,
Russell, D. G.,
and Goldberg, D. E.
(1994)
EMBO J.
13,
306-317[Medline]
[Order article via Infotrieve]
|
| 15.
|
Bryant, N. J.,
and Stevens, T. H.
(1998)
Microbiol. Mol. Biol. Rev.
62,
230-247[Abstract/Free Full Text]
|
| 16.
|
Mullins, C.,
and Bonifacino, J. S.
(2001)
Bioessays
23,
333-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Banerjee, R.,
Liu, J.,
Beatty, W.,
Pelosof, L.,
Klemba, M.,
and Goldberg, D. E.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
990-995[Abstract/Free Full Text]
|
| 18.
|
Trager, W.,
and Jensen, J. B.
(1976)
Science
193,
673-675[Abstract/Free Full Text]
|
| 19.
|
Haldar, K.,
Ferguson, M. A. J.,
and Cross, G. A. M.
(1985)
J. Biol. Chem.
260,
4969-4974[Abstract/Free Full Text]
|
| 20.
|
Akompong, T.,
VanWye, J.,
Ghori, N.,
and Haldar, K.
(1999)
Mol. Biochem. Parasitol
101,
71-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kadekoppala, M.,
Cheresh, P.,
Catron, D., Ji, D. D.,
Deitsch, K.,
Wellems, T. E.,
Seifert, H. S.,
and Haldar, K.
(2001)
Mol. Biochem. Parasitol
112,
211-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Fidock, D. A.,
Nomura, T.,
and Wellems, T. E.
(1998)
Mol. Pharmacol.
54,
1140-1147[Abstract/Free Full Text]
|
| 23.
|
Vander Jagt, D. L.,
Intress, C.,
Heidrich, J. E.,
Mrema, J. E.,
Rieckmann, K. H.,
and Heidrich, H. G.
(1982)
J. Parasitol.
68,
1068-1071[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Goldberg, D. E.,
Slater, A. F.,
Beavis, R.,
Chait, B.,
Cerami, A.,
and Henderson, G. B.
(1991)
J. Exp. Med.
173,
961-969[Abstract/Free Full Text]
|
| 25.
|
Chen, M. M.,
Shi, L.,
and Sullivan, D. J., Jr.
(2001)
Mol. Biochem. Parasitol.
113,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Howard, R. J.,
Shigehiko, U.,
Aikawa, M.,
Aley, S. B.,
Leech, J. H.,
Lew, A. M.,
Wellems, T. E.,
Rener, J.,
and Taylor, D. W.
(1986)
J. Cell Biol.
103,
1269-1277[Abstract/Free Full Text]
|
| 27.
|
Crary, J. L.,
and Haldar, K.
(1992)
Mol. Biochem. Parasitol.
53,
185-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Akompong, T.,
Ghori, N.,
and Haldar, K.
(2000)
Antimicrob. Agents Chemother.
44,
88-96[Abstract/Free Full Text]
|
| 29.
|
Waller, R. F.,
Reed, M. B.,
Cowman, A. F.,
and McFadden, G. I.
(2000)
EMBO J.
19,
1794-1802[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cheresh, P.,
Harrison, T.,
Fujioka, H.,
and Haldar, K.
(2002)
J. Biol. Chem.
277,
16265-16277[Abstract/Free Full Text]
|
| 31.
|
Goldberg, D. E.,
Slater, A. F.,
Cerami, A.,
and Henderson, G. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2931-2935[Abstract/Free Full Text]
|
| 32.
|
Kocken, C. H.,
van der Wel, A. M.,
Dubbeld, M. A.,
Narum, D. L.,
van de Rijke, F. M.,
van Gemert, G. J.,
van der Linde, X.,
Bannister, L. H.,
Janse, C.,
Waters, A. P.,
and Thomas, A. W.
(1998)
J. Biol. Chem.
273,
15119-15124[Abstract/Free Full Text]
|
| 33.
|
Wiser, M. F.,
Lanners, H. N.,
Bafford, R. A.,
and Favaloro, J. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9108-9113[Abstract/Free Full Text]
|
| 34.
|
Tormakangas, K.,
Hadlington, J. L.,
Pimpl, P.,
Hillmer, S.,
Brandizzi, F.,
Teeri, T. H.,
and Denecke, J.
(2001)
Plant Cell
13,
2021-2032[Abstract/Free Full Text]
|
| 35.
|
Gething, M. J.,
and Sambrook, J.
(1990)
Semin. Cell Biol.
1,
65-72[Medline]
[Order article via Infotrieve]
|
| 36.
|
Van Wye, J.,
Ghori, N.,
Webster, P.,
Mitschler, R. R.,
Elmendorf, H. G.,
and Haldar, K.
(1996)
Mol. Biochem. Parasitol.
83,
107-120[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles: